title: [Co-enaesthetic schizophrenia. Case studies of illness perception and compliance].
abstract: Against the background of clinical and anthropological considerations, the case studies of eleven patients with coenaesthetic schizophrenia (F 20.8 in ICD-10) are evaluated with regard to how the patients experience the disorders of corporal perception. Additional criteria for the evaluation are whether the disorders receive a special significance in dealing with the psychosis, and whether they influence compliance with medicinal intake. In two cases, the coenaesthesies were experienced as making the patients happy, they were used by the patients to strengthen themselves, and so the motivation for medicinal therapy was accordingly small. Of the remaining nine patients who suffered from the body perception disorder, five were not willing to accept neuroleptic therapy. The author ascribes this above all to two behaviours: the patients either deny their symptoms, or they attempt to use them to compensate for ego-weakness. However, an effect of self-stabilisation through the coenaesthesies, as measured by social capabilities, is not objectively recognisable.
authors.affiliation: Psychiatrische Universitätsklinik Marburg.
authors.forename: D
authors.initials: D
authors.lastname: Schmoll
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001364:Awareness; D001828:Body Image; D004532:Ego; D005260:Female; D005500:Follow-Up Studies; D005783:Gender Identity; D006801:Humans; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance / Q000523:psychology*; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000145:classification / Q000175:diagnosis* / Q000188:drug therapy; D012565:Schizophrenic Psychology; D013001:Somatoform Disorders / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy
chemical_list: D014150:Antipsychotic Agents
vernacular_title: Coenästhetische Schizophrenie. Kasuistische Untersuchungen zur Krankheitsbedeutung und Compliance.